Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5
暂无分享,去创建一个
[1] Bianca Sperl,et al. Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine , 2007, ChemMedChem.
[2] Steven Fletcher,et al. Protein-protein interaction inhibitors: small molecules from screening techniques. , 2007, Current topics in medicinal chemistry.
[3] W. Guida,et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity , 2007, Proceedings of the National Academy of Sciences.
[4] Bianca Sperl,et al. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.
[5] H. Arndt. Kleine Moleküle als Transkriptionsmodulatoren , 2006 .
[6] Hans‐Dieter Arndt. Small molecule modulators of transcription. , 2006, Angewandte Chemie.
[7] Dirk Eick,et al. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. , 2006, Chemistry & biology.
[8] B. Groner,et al. Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.
[9] L. Vassilev,et al. Targeting protein–protein interactions for cancer therapy , 2005, Journal of Molecular Medicine.
[10] Arlin G. Cameron,et al. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor. , 2005, Journal of medicinal chemistry.
[11] H. Yin,et al. Strategien zur Modulation von Protein‐Protein‐Wechselwirkungen mit synthetischen Substanzen , 2005 .
[12] A. Hamilton,et al. Strategies for targeting protein-protein interactions with synthetic agents. , 2005, Angewandte Chemie.
[13] S. Korsmeyer,et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.
[14] Michelle Arkin,et al. Protein-protein interactions and cancer: small molecules going in for the kill. , 2005, Current opinion in chemical biology.
[15] Renxiao Wang,et al. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] Jean Chmielewski,et al. Inhibiting protein-protein interactions using designed molecules. , 2005, Current opinion in structural biology.
[17] K. Audouze,et al. Emerging classes of protein-protein interaction inhibitors and new tools for their development. , 2004, Current opinion in chemical biology.
[18] Michelle R. Arkin,et al. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.
[19] R. Jove,et al. Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2. , 2003, Cancer research.
[20] J. Grandis,et al. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. , 2003, Cancer research.
[21] A. Ullrich,et al. Beyond Herceptin and Gleevec. , 2003, Current opinion in chemical biology.
[22] T. Berg. Modulation von Protein‐Protein‐Wechselwirkungen mit niedermolekularen organischen Molekülen , 2003 .
[23] T. Berg. Modulation of protein-protein interactions with small organic molecules. , 2003, Angewandte Chemie.
[24] T. Mayer,et al. Chemical genetics: tailoring tools for cell biology. , 2003, Trends in cell biology.
[25] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[26] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[27] R. Jove,et al. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] D. Lejeune,et al. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells. , 2000, Cancer research.
[29] Horst Kessler,et al. N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .
[30] M. Battegay,et al. Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells. , 1998, European journal of biochemistry.
[31] P. Heinrich,et al. Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation , 1996, FEBS letters.
[32] J. Ihle,et al. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response , 1996, Molecular and cellular biology.